Mainline Health Approved for Naloxone Hero Program

MONTICELLO — Mainline Health Systems has been approved for funding through the ARORP Naloxone Hero Program and will receive support from the Arkansas Naloxone Bank to expand access to naloxone for families and community members across south Arkansas. This award represents a meaningful investment in overdose prevention, public safety, and community health throughout the region.Through this funding, Mainline Health Systems will receive $14,208.00 to obtain naloxone for dissemination in Ashley, Bradley, Chicot, Cleveland, Drew, Lincoln, Columbia, Grant, and surrounding areas, as outlined in the approved application. The program period will officially run from May 18, 2026, through May 18, 2027, supporting year-long efforts to prevent overdose-related deaths while increasing access to life-saving resources for those at risk and the individuals who care for them.Naloxone is a proven, life-saving medication that reverses the effects of opioid overdoses when administered promptly. Expanded access to naloxone empowers families, friends, first responders, and community members to take immediate action during overdose emergencies and strengthens local response efforts across rural and underserved communities.“We are grateful for this opportunity to expand access to naloxone across the communities we serve,” said Ashley Anthony, Chief Operating Officer of Mainline Health Systems. “This funding allows us to put critical, life-saving resources into the hands of families and community members while reinforcing our ongoing work to address substance use disorder through prevention, education, and timely intervention.”Mainline Health Systems’ participation in the Naloxone Hero Program aligns with the organization’s broader mission to improve health outcomes and reduce barriers to care. In addition to direct naloxone distribution, the initiative will support community outreach, education, and awareness aimed at reducing stigma ...

To access content, please login or purchase a subscription.